NCT04466215View on ClinicalTrials.gov

Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

June 7, 2022

Conditions
Alcohol Use Disorder
Interventions
DRUG

Miricorilant

900 mg (6 x 150 mg) tablets taken orally once daily for two weeks

DRUG

Placebo oral tablet

Six placebo tablets taken orally once daily for two weeks

Trial Locations (1)

92037

The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, La Jolla

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

The Scripps Research Institute

OTHER